MET-815i
Phase 1
PfizerMET-815i is one of 10 therapeutic programs targeting Age. It is currently in Phase 1.
1
Indications
0
Total Trials
0
Active Trials
9
Competitors
Pipeline
Status by Indication[1]
Competition
Competitive Landscape
13 competitors in Age
#DrugCompanyPhaseTrials
1Actigall
AbbVieApproved
Rapamune
PPrism Pharmaceuticals
Approved
RG6026
RochePhase 2
Revia
TevaPreclinical
Pitocin
RRetrophin
Preclinical
Ambien
PPurdue Pharma LP
Preclinical
Feosol
AAuerbach Hematology Oncology Associates P C
Preclinical
Mrna-3927
ModernaPhase 1
Sodium Nitrite
HHope Pharmaceuticals
Preclinical
MET-815i
PfizerPhase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Sources
References
- [1]Open Targets Platform — Drug–disease associations for MET-815i. EMBL-EBI & Wellcome Sanger Institute.
- [2]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 1
- Company